Expression and purification of recombinant human indoleamine 2,3-dioxygenase

Protein Expression and Purification

Volumn 19, Issue 1, 2000, Pages 22-29

  Littlejohn, Tamantha K ^a   Takikawa, Osamu ^a   Skylas, Daniel ^a   Jamie, Joanne F ^a   Walker, Mark J ^a   Truscott, Roger J W ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; ABSORPTION; AFFINITY CHROMATOGRAPHY; BACTERIUM CULTURE; CELLULOSE PHOSPHATE; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME SUBSTRATE; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENETIC STRAIN; HEMIN; HYBRID PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; RECOMBINANT ENZYME; TRYPTOPHAN;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0034045477     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.2000.1214     Document Type: Article

References (47)

1. Hayaishi O., Takikawa O., Yoshida R. Indoleamine 2,3-dioxygenase: Properties and function of a superoxide utilizing enzyme. Lippard S. J. Progress in Inorganic Chemistry-Bioinorganic Chemistry. 1990;75-95 Wiley, New York.
2. Brown R. Metabolism and biology of tryptophan. Filippini G. F., Costa C. V. L., Bertazzo A. Recent Advances in Tryptophan Research. 1996;15-25 Plenum Press, New York.
3. Takikawa O., Yoshida R., Kido R., Hayaishi O. Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J. Biol. Chem. 258:1986;3648-3653.
4. Yoshida R., Urade Y., Tokuda M., Hayaishi O. Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection. Proc. Natl. Acad. Sci. USA. 76:1979;4084-4086.
5. Saito K., Lankner A., Markey S. P., Heyes M. P. Cerebral cortex and lung indoleamine 2,3-dioxygenase activity is increased in type-D retrovirus infected macaques. Brain Res. 540:1991;353-356.
6. Heyes M. P., Saito K., Jacobowitz D., Markey S. P., Takikawa O., Vickers J. H. Poliovirus induces indoleamine 2,3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J. 6:1992;2977-2989.
7. Reinhard J. F. Jr. Altered tryptophan metabolism in mice with herpes simplex virus encephalitis: Increases in spinal cord quinolinic acid. Neurochem. Res. 23:1998;661-665.
8. Yoshida R., Hayaishi O. Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 75:1978;3998-4000.
9. Sanni L. A., Thomas S. R., Tattam B. N., Moore D. E., Chaudhri G., Stocker R., Hunt N. H. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am. J. Pathol. 152:1998;611-619.
10. Takikawa O., Habara-Ohkubo A., Yoshida R. IFN-γ is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. J. Immunol. 145:1990;1246-1250.
11. Holmes E. W., Russell P. M., Kinzler G. J., Reckard C. R., Flanigan R. C., Thompson D., Bermes E. W. Jr. Oxidative tryptophan metabolism in renal allograft recipients: Increased kynurenine synthesis is associated with inflammation and OKT3 therapy. Cytokine. 4:1992;205-213.
12. Burke F., Knowles R. G., East N., Balkwill F. R. The role of indoleamine 2,3-dioxygenase in the anti-tumor activity of human interferon-gamma in vivo. Int. J. Cancer. 60:1995;115-122.
13. Dias S., Thomas H., Balkwill F. R. Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model. Int. J. Cancer. 75:1998;151-157.
14. Yu W. G., Yamamoto N., Takenaka H., Mu J., Tai X.-G., Zou J.-P., Ogawa M., Tsutsui T., Wijesuriya T., Yoshida R., Hermann S., Fujiwara H., Hamaoka T. Molecular mechanisms underlying IFN-γ-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12. Int. Immunol. 8:1996;855-865.
15. Pfefferkorn E. R. Interferon blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA. 81:1984;908-912.
16. Byrne G. I., Lehmann L. K., Landry G. J. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 53:1986;347-351.
17. Takikawa O., Kuroiwa T., Yamazaki F., Kido R. Mechanism of IFN-γ action: Characterization of indoleamine 2,3-dioxygenase in various human cells induced by IFN-γ and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 263:1988;2041-2048.
18. Ozaki Y., Edelstein M. P., Duch D. S. Induction of indoleamine 2,3-dioxygenase: A mechanism of the antitumor activity of interferon gamma. Proc. Natl. Acad. Sci. USA. 85:1988;1242-1246.
19. de la Maza L. M., Peterson E. M. Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media. Cancer Res. 48:1988;346-350.
20. MacKenzie C. R., Hadding U., Daubener W. Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci. J. Infect. Dis. 178:1998;875-878.
21. Bodaghi B., Goureau O., Zipeto D., Laurent L., Virelizier J. L., Michelson S. Role of IFN-gamma-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J. Immunol. 162:1999;957-964.
22. Munn D. H., Zhou M., Attwood J. T., Bondarev I., Conway S. J., Marshall B., Brown C., Mellor A. L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 28:1998;1191-1193.
23. Munn D. H., Shafizadeh E., Attwood J. T., Bondarev I., Pashine A., Mellor A. L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189:1999;1363-1372.
24. Schwarcz R., Whestsell W. O., Mangano R. E. M. Quinolinic acid: An endogenous metabolite can produce axon-sparing lesions in rat brain. Science. 219:1983;316-318.
25. Sardar A. M., Reynolds G. P. Frontal cortex indoleamine 2,3-dioxygenase is increased in HIV-1-associated dementia. Neurosci. Lett. 187:1995;9-12.
26. Kerr S. J., Armati P. J., Pemberton L. A., Smythe G., Tattam B., Brew B. J. Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages. Neurology. 49:1997;1671-1681.
27. Heyes M. P., Saito K., Lackner A., Wiley C. A., Achim C. L., Markey S. P. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J. 12:1998;881-896.
28. Heyes M. P., Saito K., Chen C. Y., Proescholdt M. G., Nowak T. S. Jr., Li J., Beagles K. E., Proescholdt M. A., Zito M. A., Kawai K., Markey S. P. Species heterogeneity between gerbils and rats: Quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation. J. Neurochem. 69:1997;1519-1529.
29. Saito K., Nowak T. S. Jr., Markey S. P., Heyes M. P. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J. Neurochem. 60:1993;180-192.
30. Okuda S., Nishiyama N., Saito H., Katsuki H. Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc. Natl. Acad. Sci. USA. 93:1996;12553-12558.
31. Pearson S. J., Reynolds G. P. Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease. Neurosci. Lett. 144:1992;199-201.
32. Aquilina J. A., Carver J. A., Truscott R. J. W. Oxidation of products of 3-hydroxykynurenine bind to lens proteins: Relevance for nuclear cataract. Exp. Eye Res. 64:1997;727-735.
33. Eguchi N., Watanabe Y., Kawanishi K., Hashimoto Y., Hayaishi O. Inhibition of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by beta-carboline and indole derivatives. Arch. Biochem. Biophys. 232:1984;602-609.
34. Cady S. G., Sono M. 1-Methyl-dl-tryptophan, beta-(3-benzofuranyl)-dl-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-dl-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch. Biochem. Biophys. 291:1991;326-333.
35. Peterson A. C., La Loggia A. J., Hamaker L. K., Arend R. A., Fisette P. L., Ozaki Y., Will J. A., Brown R. R., Cook J. M. Evaluation of substituted β-carbolines as noncompetitive indoleamine 2,3-dioxygenase inhibitors. Med. Chem. Res. 3:1993;473-482.
36. Peterson A. C., Migawa M. T., Martin M. J., Hamaker L. K., Czerwinski K. M., Zhang W., Arend R. A., Fisette P. L., Ozaki Y., Will J. A., Brown R. R., Cook J. M. Evaluation of functionalized tryptophan derivatives and related compounds as competitive inhibitors of indoleamine 2,3-dioxygenase inhibitors. Med. Chem. Res. 3:1994;531-544.
37. Southan M. D., Truscott R. J. W., Jamie J. F., Pelosi L., Walker M. J., Maeda H., Iwamoto Y., Tone S. Structural requirements of the competitive binding site of recombinant human indoleamine 2,3-dioxygenase. Med. Chem. Res. 6:1996;343-352.
38. Maeda H., Tone S., Kadoya A., Iwamonoto Y., Minatogawa Y., Kido R. Expression of human indoleamine 2,3-dioxygenase in E. coli. Ishiguro I., Kido R., Nagatsu T., Nagamura Y., Ohta Y. Advances in Tryptophan Research. 1992;417-420 Fujita Health Univ. Press, Toyoake.
39. Smith D. B., Johnson K. S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 67:1988;31-40.
40. Holzinger A., Phillips K. S., Weaver T. E. Single-step purification/solubilization of recombinant proteins: Applications to surfactant protein B. Biotechniques. 20:1996;804-808.
41. Janknecht R., de Martynoff G., Lou J., Hipskind R. A., Nordheim A., Shunnenberg H. G. Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus. Proc. Natl. Acad. Sci. USA. 88:1991;8972-8976.
42. Mizushima S., Yamada H. Isolation and characterisation of two outer membrane preparations from Escherichia coli. Biochim. Biophys. Acta. 1975.
43. Gornall A. G., Bardawill C. J., David M. M. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 177:1949;751-766.
44. White K. A., Marletta M. A. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry. 28:1992;6627-6631.
45. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
46. Boyd V. L., Bozzini M., Zon G., Noble R. L., Mattaliano R. J. Sequencing of peptides and proteins from the carboxyl terminus. Anal. Biochem. 206:1992;344-352.
47. Richards M. K., Marletta M. A. Characterization of neural nitric oxide synthase and a C415H mutant, purified from a baculovirus overexpression system. Biochemistry. 33:1994;14723-14732.